Società Takeda Pharmaceutical Company Limited Mexican S.E.

TAK N

US8740602052

Prodotti farmaceutici

Consensus Analisti

Attività

Vendite per attività

Vendite per regione

Dirigenti

Amministratori

Classe di azioni

Azionisti

Partecipazioni

Coordinate società

Società del gruppo

Settore

Vendite per attività

Vendite per regione

Rating per Takeda Pharmaceutical Company Limited

Revisioni EPS

Utili trimestrali - Indice di sorpresa

Settore Prodotti farmaceutici - Altri

Prezzo di chiusura Mexican S.E. Altri mercati azionari 00:00:00 20/06/2024			Variaz. 5gg	Var. 1 gen.
231,5 ^MXN	-3,73%		-.--%	-3,42%

03/07	Blackstone vende il produttore di farmaci giapponese Alinamin a MBK Partners	RE
02/07	Il sistema FreedomEdge di Koru Medical Systems riceve l'approvazione normativa in Giappone	MT

Takeda Pharmaceutical Company Limited è specializzata nello sviluppo, nella produzione e nella commercializzazione di prodotti farmaceutici, in particolare per le malattie metaboliche e cardiovascolari, i tumori e i disturbi del sistema nervoso centrale. L'attività è organizzata in 2 aree:
- vendita di farmaci e prodotti di consumo;
- servizi.
Le vendite nette sono distribuite geograficamente come segue: Giappone (17,5%), Asia (5%), Stati Uniti (49%), Europa e Canada (20,8%), America Latina (3,8%), Russia e CSI (1,8%) e altro (2,1%).

Numero di dipendenti: 49 281

JPY in Milioni	2023	Peso	2024	Peso	Delta
Gastroenterology 28,5 %	1 094 541	27,2 %	1 216 207	28,5 %	+11,12%
Plasma-derivatives Therapies Immunology 19,2 %	678 443	16,8 %	818 570	19,2 %	+20,65%
Neuroscience 14,7 %	637 711	15,8 %	627 014	14,7 %	-1,68%
Rare Genetics and Other 10,9 %	418 724	10,4 %	465 403	10,9 %	+11,15%
Oncology 10,8 %	438 742	10,9 %	462 362	10,8 %	+5,38%
Other 8,7 %	454 598	11,3 %	368 908	8,7 %	-18,85%
Rare Hematology 7,2 %	304 718	7,6 %	305 297	7,2 %	+0,19%

JPY in Milioni	2023	Peso	2024	Peso	Delta
United States 51,5 %	2 103 772	52,2 %	2 195 711	51,5 %	+4,37%
Europe and Canada 22,7 %	842 668	20,9 %	966 835	22,7 %	+14,73%
Japan 10,6 %	512 043	12,7 %	451 391	10,6 %	-11,85%
Asia 6,1 %	225 007	5,6 %	261 218	6,1 %	+16,09%
Latin America 4,6 %	160 375	4,0 %	198 100	4,6 %	+23,52%
Other 2,8 %	95 182	2,4 %	117 911	2,8 %	+23,88%
Russia / Commonwealth of Independent States 1,7 %	88 431	2,2 %	72 594	1,7 %	-17,91%

Dirigenti	Titolo	Età	Da
Christophe Weber CEO	Chief Executive Officer	57	01/04/14
Mwana Lugogo CMP	Compliance Officer	54	01/01/12
Michael Mendelsohn CTO	Chief Tech/Sci/R&D Officer	69	01/04/15
Andrew Plump CTO	Chief Tech/Sci/R&D Officer	58	01/02/15
Gabriele Ricci CTO	Chief Tech/Sci/R&D Officer	45	01/02/22
Norimasa Takeda CMP	Compliance Officer	-	-
Haruhiko Hirate IRO	Public Communications Contact	-	-
Takashi Okubo IRO	Public Communications Contact	-	-
Christopher O'Reilly IRC	Investor Relations Contact	-	01/06/11
Marcello Agosti PRN	Corporate Officer/Principal	53	01/01/19

Amministratori	Titolo	Età	Da
Yoshiaki Fujimori BRD	Director/Board Member	72	01/06/16
Ian Clark BRD	Director/Board Member	62	01/01/19
Steven Gillis BRD	Director/Board Member	71	01/01/19
John Maraganore BRD	Director/Board Member	60	01/06/22
Emiko Higashi BRD	Director/Board Member	64	01/06/16
Masami Iijima CHM	Chairman	73	01/06/21
Koji Hatsukawa BRD	Director/Board Member	72	01/06/16
Christophe Weber CEO	Chief Executive Officer	57	01/04/14
Andrew Plump CTO	Chief Tech/Sci/R&D Officer	58	01/02/15
Kimberly Reed BRD	Director/Board Member	53	01/06/22

	Voto	Quantità	Flottante	Autocontrollo	Flottante totale
Azione A	0	1 582 418 640	1 568 501 201 ( 99,12 %)	13 405 000 ( 0,8471 %)	99,12 %

Nome	Azioni	%	Valorizzazione
BlackRock Fund Advisors 3,496 %	55 319 129	3,496 %	1 469 M $
BlackRock Japan Co. Ltd. 2,276 %	36 020 800	2,276 %	957 M $
Nikko Asset Management Co., Ltd. 2,194 %	34 711 100	2,194 %	922 M $
Nippon Life Insurance Co. 1,564 %	24 752 000	1,564 %	657 M $
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0,4749 %	7 514 200	0,4749 %	200 M $
BlackRock Investment Management (UK) Ltd. 0,3774 %	5 972 275	0,3774 %	159 M $
BlackRock (Netherlands) BV 0,2850 %	4 509 380	0,2850 %	120 M $
Takeda Pharmaceutical Employee Incentive Plan 0,2294 %	3 630 339	0,2294 %	96 M $
IYOGIN HOLDINGS,INC. 0,1818 %	2 876 136	0,1818 %	76 M $
Sumitomo Mitsui Trust Asset Management Co., Ltd. 0,1642 %	2 598 200	0,1642 %	69 M $

Nome	Azioni	%	Valorizzazione
Nikko Asset Management Co., Ltd. 2,762 %	87 400 834	2,762 %	1 167 M $
Capital Research & Management Co. (Global Investors) 0,4146 %	13 121 930	0,4146 %	175 M $
Mondrian Investment Partners Ltd. 0,3817 %	12 079 962	0,3817 %	161 M $
Eaton Vance Management 0,1578 %	4 995 623	0,1578 %	67 M $
The Ayco Co. LP 0,1330 %	4 209 431	0,1330 %	56 M $
Renaissance Technologies LLC 0,0985 %	3 118 200	0,0985 %	42 M $
Brandes Investment Partners LP 0,0917 %	2 902 507	0,0917 %	39 M $
Fidelity Management & Research Co. LLC 0,0813 %	2 574 240	0,0813 %	34 M $
Wells Fargo Bank NA 0,0813 %	2 571 467	0,0813 %	34 M $
Millennium Management LLC 0,0734 %	2 322 444	0,0734 %	31 M $

Nome	Azioni	%	Valorizzazione
BB Gestão de Recursos DTVM SA 0,000068 %	1 076	0,000068 %	14 302 $

Nome	Azioni	%	Valorizzazione
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0.47%	7 514 200	0.47%	199 540 257 $
HILLEVAX, INC. 13.52%	6 724 000	13.52%	81 629 360 $
DENALI THERAPEUTICS INC. 2.96%	4 214 559	2.96%	78 222 215 $
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD. 7.21%	2 204 000	7.21%	33 085 588 $
OVID THERAPEUTICS INC. 12.38%	8 781 996	12.38%	26 872 908 $
PHATHOM PHARMACEUTICALS, INC. 4.77%	2 790 480	4.77%	26 286 322 $
WAVE LIFE SCIENCES LTD. 0.90%	1 096 892	0.90%	6 778 793 $
NOILE-IMMUNE BIOTECH INC. 18.76%	8 119 800	18.76%	6 768 828 $

Takeda Pharmaceutical Co., Ltd.

4-1-1 Dosho-machi Chuo-Ku

540-8645, Osaka

+81 3 3278-2111

http://www.takeda.co.jp

Indirizzo Takeda Pharmaceutical Company Limited(TAK N)

Nome	Categoria e settore
Shire Biotech India Pvt Ltd.
Takeda Austria GmbH Takeda Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Austria GmbH engages in research and development of pharmaceutical products. The company is based in Linz, Austria. Kirsten Detrick has been the CEO of the Austrian company since 2016.	Miscellaneous Commercial Services
Takeda Belgium NV Takeda Belgium NV Medical DistributorsDistribution Services Founded in 1835, Takeda Belgium NV is a subsidiary of Takeda Pharmaceutical Co., Ltd. The company is based in Zaventem, Belgium and focuses on providing better healthcare solutions for their patients. Takeda Belgium's mission is centered around the question of how they can do more for their patients.	Medical Distributors
Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL.	Pharmaceuticals: Major
Takeda GmbH Takeda GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Konstanz, Germany. The CEOs are Wolfgang Eck, Uwe Hoffmeister, Roland Kurney. The company was founded in 1873.	Pharmaceuticals: Major
Shire Ireland Finance Trading Ltd.
Shire Biotech UK Holdings Ltd. Shire Biotech UK Holdings Ltd. Financial ConglomeratesFinance Part of Takeda Pharmaceutical Co., Ltd., Shire Biotech UK Holdings Ltd. is an investment holding company. Shire Biotech UK Holdings Ltd. is based in London, UK. Founded in 2017, Shire Biotech UK Holdings functions as an investment holding company.	Financial Conglomerates
Takeda Manufacturing Austria AG Takeda Manufacturing Austria AG Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Manufacturing Austria AG manufactures and supplies vital medicines and medical devices. The company is based in Vienna, Austria.	Pharmaceuticals: Major
Takeda A/S Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.	Financial Conglomerates
Takeda Pharmaceuticals International AG Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland.	Pharmaceuticals: Major

Rating Trading

Rating Investimento

ESG Refinitiv

Altri rating

Vendita

Buy

Raccomandazione media

Accumulate

Numero di analisti

Ultimo prezzo di chiusura

4.243 JPY

Prezzo obiettivo medio

4.744 JPY

Differenza / Target Medio

+11,82%

Consenso

Revisioni delle Stime

Calendario della società

Biotecnologia/Farmaceutici

Biotecnologia/Farmaceutici

Prodotti farmaceutici

Prodotti farmaceutici - Altri

	Variaz. 1 gen.	Capi.
ELI LILLY AND COMPANY	+56,88%	809 Mrd
NOVO NORDISK A/S	+39,52%	624 Mrd
JOHNSON & JOHNSON	-7,18%	351 Mrd
ABBVIE INC.	+7,23%	289 Mrd
ASTRAZENECA PLC	+13,74%	240 Mrd
NOVARTIS AG	+13,83%	220 Mrd
ROCHE HOLDING AG	-0,49%	219 Mrd
AMGEN INC.	+7,93%	166 Mrd
PFIZER, INC.	-2,73%	157 Mrd

Prodotti farmaceutici - Altri